Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6384 Neoplasms 5356 Prostatic Neoplasms 2964 Carcinoma, Non-Small-Cell Lung 2704 Colorectal Neoplasms 2674 Lung Neoplasms 2262 Multiple Myeloma 1656 Lymphoma 1598 Neoplasm Metastasis 1550 Leukemia, Myeloid, Acute 1537 Melanoma 1484 Pancreatic Neoplasms 1470 Ovarian Neoplasms 1420 Leukemia 1387 Head and Neck Neoplasms 1283 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1279 Lymphoma, Non-Hodgkin 1226 Colonic Neoplasms 1157 Carcinoma, Hepatocellular 1141 Stomach Neoplasms 1126 Leukemia, Lymphocytic, Chronic, B-Cell 1089 Brain Neoplasms 1048 Rectal Neoplasms 979 Lymphoma, Follicular 978 Recurrence 971 Uterine Cervical Neoplasms 923 Glioblastoma 916 Carcinoma, Renal Cell 881 Lymphoma, Large B-Cell, Diffuse 851 Hodgkin Disease 775

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Endocrine Tumors × Clear all

NCT00353496 2025-03-05

CLARINET

Ipsen

Phase 3 Completed

264 enrolled 17 charts

Endocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡